10x Genomics
Builds Chromium, Visium, Xenium, and Atera platforms for single-cell and spatial biology.
$61.54
After-hours close−0.01 (−0.01%)
At close$61.55(−5.10%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 105.62%Insiders 1.99%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 126.96M · Float 114.79M · 90.4% free float
Institutions13F, as of Jun 30, 2026
402 holders · 134.09M shares · 102 new positions · 204 increased · 138 reduced · 41 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 17.63M | 13.89% | −111.7K | Aug 13, 2026 |
| BlackRock, Inc. | 10.80M | 8.51% | +724.2K | Aug 7, 2026 |
| Ark Investment Management LLC | 10.00M | 7.88% | −1.71M | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 6.98M | 5.50% | +69.6K | Aug 13, 2026 |
| Quantinno Capital Management LP | 5.47M | 4.31% | +57.9K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 5.08M | 4.00% | −187.0K | Aug 13, 2026 |
| Price T Rowe Associates Inc /MD/ | 4.54M | 3.58% | +4.38M | Aug 14, 2026 |
| Sumitomo Mitsui Trust Group, Inc. | 4.19M | 3.30% | −915.6K | Jul 30, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 15.60% | 18.54M | 13G | Mar 6, 2026 ↗ |
| ARK Investment Management LLC | 10.39% | 11.89M | 13G | Nov 4, 2025 ↗ |
| BlackRock, Inc. | 7.60% | 8.50M | 13G | Jul 16, 2025 ↗ |
| Sumitomo Mitsui Trust Group, Inc. (“SMTG”)incl. Nikko Asset Management Co., Ltd. (“NAM”) | 5.98% | 6.37M | 13G | Nov 5, 2024 ↗ |
| Vanguard Portfolio Management | 5.93% | 6.98M | 13G | Apr 28, 2026 ↗ |
| Nikko Asset Management Americas, Inc. | 5.40% | 6.01M | 13G | Aug 13, 2025 ↗ |
| Vanguard Capital Management | 5.24% | 6.17M | 13G | Apr 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Serge Saxonov | director, officer: Chief Executive Officer | 1.08M | 0.85% | Aug 28, 2026 |
| Benjamin J. Hindson | director, officer: See Remarks | 488.2K | 0.38% | Aug 26, 2026 |
| Adam Taich | officer: Chief Financial Officer | 362.7K | 0.29% | Aug 26, 2026 |
| John R. Stuelpnagel | director | 348.4K | 0.27% | Aug 13, 2026 |
| Alan Mateo | director | 85.9K | 0.07% | Jun 8, 2026 |
| Sridhar Kosaraju | director | 65.3K | 0.05% | Jun 8, 2026 |
| Kimberly J. Popovits | director | 37.4K | 0.03% | Jun 8, 2026 |
| Shehnaaz Suliman | director | 29.5K | 0.02% | Aug 26, 2026 |
| Sarah A. Teichmann | director | 28.1K | 0.02% | Aug 17, 2026 |
4 ten-percent owners hold 19.63M shares by Form 4, outside the officers-and-directors figure above · 6 people have not refiled in the last 18 months (726.1K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 26, 2026 | Serge Saxonovdirector, officer: Chief Executive Officer | Sale · 3 lots | 10,486 | $63.69 | 1,075,349 |
| Aug 24, 2026 | Adam Taichofficer: Chief Financial Officer | Sale | 17,166 | $63.02 | 362,732 |
| Aug 24, 2026 | Serge Saxonovdirector, officer: Chief Executive Officer | Sale | 18,545 | $63.02 | 1,085,835 |
| Aug 24, 2026 | Shehnaaz Sulimandirector | Sale · 2 lots | 2,207 | $63.65 | 29,515 |
| Aug 24, 2026 | Benjamin J. Hindsondirector, officer: See Remarks | Sale | 13,818 | $63.02 | 488,182 |
| Aug 14, 2026 | Sarah A. Teichmanndirector | Sale | 2,273 | $57.15 | 28,058 |
| Aug 13, 2026 | Sarah A. Teichmanndirector | Sale | 5,278 | $57.29 | 30,331 |
| Aug 11, 2026 | John R. Stuelpnageldirector | Sale · 2 lots | 20,000 | $57.75 | 348,436 |
| Jun 22, 2026 | Serge Saxonovdirector, officer: Chief Executive Officer | Sale · 4 lots | 30,000 | $34.44 | 1,108,380 |
| Jun 16, 2026 | Shehnaaz Sulimandirector | Sale · 2 lots | 5,723 | $32.63 | 31,722 |
CongressHouse and Senate disclosures
Not reported.